Gucci Beauty Clash Puts Luxury Licensing Under the Microscope

The future of the Gucci beauty business made headlines this fall when Kering announced that it would sell its beauty division to L’Oréal in a €4 billion deal. What began as a transactional announcement about the future of Kering’s beauty operations – and by extension, its valuable Gucci beauty range – has since given rise to formal court proceedings centered on a deceptively narrow question: What can a brand owner promise about tomorrow while today’s license remains in force?

That question is now before a U.K. commercial court, where a Swiss subsidiary of Coty Inc. is challenging aspects of the deal, which closed on March 31 following approval from competition authorities. Although Coty’s Gucci beauty and fragrance license runs through 2028, recent public statements by Kering and L’Oréal indicate that discussions about accelerating the transition are underway, potentially complicating what had been positioned as a post-2028 transition.

Behind the Kering-L’Oréal Deal

The Coty-initiated clash got its start on October 19, 2025 when Kering announced that it would sell its beauty division to L’Oréal in a €4 billion transaction that includes the Creed fragrance brand and the beauty licenses for Balenciaga and Saint Laurent. It also grants L’Oréal an option to enter into an exclusive 50-year Gucci beauty and fragrance license once Coty’s current agreement expires in 2028.

Within 24 hours, Coty’s Swiss subsidiary filed suit in the U.K. Commercial Court against Gucci America Inc., Guccio Gucci SpA, and Kering SA. The complaint has not been publicly detailed, but the timing – and commentary from the parties, themselves – strongly suggests that Coty views the forward allocation of Gucci’s long-term beauty rights as legally consequential to its existing agreement.

Coty has maintained that there has been no change to its license and that it intends to defend its contractual rights “until the last day” of the agreement. Kering, in turn, has rejected the allegations and confirmed that it will vigorously defend its position. The license remains formally intact through 2028.

From Succession Plan to Active Discussion?

Commentary from both companies suggests that the timing of a potential transition remains unsettled. Speaking to analysts on a Kering earnings call on February 10, CEO Luca de Meo stated that the group “continue[s] to respect all our engagement and the contract” and indicated that any discussion about the future of the license would be addressed directly with Coty. At the same time, he declined to speculate on whether Kering might seek to take back the license before its 2028 expiration, offering neither confirmation of an early transition nor an explicit rejection of the possibility.

Three days later, L’Oréal’s CEO, Nicolas Hieronimus stated that the company “would be happy to get the brand sooner” than 2028 if possible. He confirmed that early access to the Gucci license is a subject of discussion between Kering and Coty, although he declined to provide details. Neither Kering nor Coty commented in that report. In other words, a binding agreement has been announced, but it has been openly acknowledged by the parties.

The Contractual Pressure Point

Coty currently holds the exclusive right to develop and sell Gucci-branded beauty products through 2028. The license generates approximately $600 million in annual retail sales and stands as one of Coty’s most significant prestige assets – making the stability of the remaining term commercially critical.

Against that backdrop, the emerging legal spat appears less about formal termination and more about potential commercial impairment. Luxury beauty licenses depend on multi-year product pipelines, retailer commitments, and sustained marketing investment. Public signals that a brand’s future operator has already been identified can influence market perception of the incumbent’s long-term position, with possible downstream effects on sales momentum, investment decisions, and negotiating leverage during the balance of the contract. If retailers, distributors, or internal teams treat the license as transitional, the commercial value of the remaining term could erode before expiration. That risk likely explains Coty’s decision to file suit.

From a legal standpoint, the case may turn on whether Kering’s agreement with L’Oréal violates any exclusivity provisions, non-impairment clauses, or implied duties of good faith and fair dealing embedded in Coty’s existing contract. The fact that no early termination has occurred does not eliminate the possibility of contractual friction if forward commitments are deemed to undermine the present license.

Even without an early termination, the risk of a contract dispute remains if forward-facing commitments are seen as undermining the current license.

For Kering, the transaction reflects long-term brand consolidation. Aligning Gucci beauty with L’Oréal provides scale, technical capability, and continuity within a global prestige beauty infrastructure. For L’Oréal, Gucci represents a major strategic addition. Securing the license earlier would accelerate integration and eliminate a multi-year waiting period.

For Coty, however, Gucci remains an active revenue engine through 2028. The company has publicly stated that its rights remain fully operative, but the market now understands that discussions about timing are underway. And that shift – from distant expiration to near-term negotiation – is material to Coty’s financial outlook and bargaining position during the remaining life of the license.

THE OUTLOOK: As of now, Coty retains the Gucci beauty license through 2028. Kering has publicly stated that it respects the existing contract. L’Oréal has expressed interest in earlier access and confirmed that discussions are occurring. No agreement accelerating the transition has been announced. The lawsuit remains pending in the U.K.

The central question is no longer simply who will control Gucci beauty after 2028, but whether the path to that transition can be advanced without breaching the existing agreement. In luxury licensing, succession planning is expected. What is contested here is timing – and whether forward commitments can lawfully coexist with a still-active contract.